Daniel Tillett Insider Profile
25 Followers
Daniel Tillett, Chief Executive Officer & Managing Director, Ten Percent Owner at Race Oncology Ltd., holds 20.29M shares in Race Oncology Ltd. (Ticker: AU:RAC), holds 67.00M shares in Tryptamine Therapeutics (Ticker: AU:ENP), holds 44.19M shares in Simble Solutions Ltd. (Ticker: AU:SIS). Most recently, Daniel Tillett Bought ― shares of Race Oncology Ltd. on Sep 29, 2026 for an estimated value of AU$45.70K.
Daniel Tillett's Trading History
You May Also Like
Daniel Tillett insider profile FAQ
What is the percentage of profitable transactions made by Daniel Tillett?
The percentage of profitable transactions made by Daniel Tillett is 21%.
What is the average return per transaction made by Daniel Tillett?
The average return per transaction made by Daniel Tillett is 94.20%.
What stocks does Daniel Tillett hold?
Daniel Tillett holds: AU:RAC, AU:ENP, AU:SIS stocks.
What was Daniel Tillett’s latest transaction?
Daniel Tillett’s latest transaction was an Informative Buy of AU$45.70K.
What was Daniel Tillett's most profitable transaction?
Daniel Tillett’s most profitable transaction was an Informative Buy of AU:RAC stock on December 5, 2019. The return on the trade was 800.00%.
What is Daniel Tillett's role in Race Oncology Ltd.?
Daniel Tillett's role in Race Oncology Ltd. is Chief Executive Officer & Managing Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
